Researchers who oppose the use of exogenous albumin insisted that hypoalbuminemia is not a modifiable factor that can improve postoperative outcomes, but a result of poor prognosis after pancreatectomy [8]. The gene discussed is ALB; the disease is Hypoalbuminemia.